Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mueller

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
The New England Journal of Medicine|August 2, 2013
Efficacy of remission-induction regimens for ANCA-associated vasculitisUlrich Specks, Peter A Merkel, Philip Seo, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
The New England Journal of Medicine|August 2, 2013
Efficacy of remission-induction regimens for ANCA-associated vasculitisUlrich Specks, Peter A Merkel, Philip Seo, et al.
Pageof 4